HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
CCLV Cat# CCLV-RIE 0082, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
CCLV |
CCLV-RIE 0082 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-09-05 11:02:41 |
39236 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
KCLB Cat# 10002, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
KCLB |
10002 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-09-05 11:02:41 |
39236 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
Abcam Cat# ab271142, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
Abcam |
ab271142 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-09-05 11:02:41 |
39236 |
HT-1080
Resource Report
Resource Website
1000+ mentions
Discontinued Discontinued
|
RRID:CVCL_0317
|
Homo sapiens (Human)
|
Fibrosarcoma
|
Caution: This cell line is considered by some researchers to represent a dedifferentiated chondrosarcoma due to the presence of an IDH1 mutation (PubMed=26368816)., Anecdotal: One of the 3 cell lines (HT-1080, RD and SK-N-SH) where the NRAS oncogene was first identified (PubMed=6304521)., Population: Caucasian., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: ENCODE project common cell types; tier 3., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:375235 PMID:3335022 PMID:3413074 PMID:3558490 PMID:3986962 PMID:4132053 PMID:6304521 PMID:6538202 PMID:6652615 PMID:11416159 PMID:11668190 PMID:12068308 PMID:17254797 PMID:20164919 PMID:20215515 PMID:22282976 PMID:22460905 PMID:24726063 PMID:25485619 PMID:25877200 PMID:26351324 PMID:26368816 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
Ht-1080, HT 1080, HT1080, HT 1080.T |
|
|
BTO:BTO_0001282, CLO:CLO_0004266, CLO:CLO_0004276, EFO:EFO_0002059, MCCL:MCC:0000210, CLDB:cl1735, CLDB:cl1736, CLDB:cl1737, CLDB:cl1738, CLDB:cl1740, CLDB:cl1741, CLDB:cl1742, CLDB:cl4913, ABM:T8971, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CCL-121, ATCC:CRL-7951, BCRC:60037, BCRJ:0110, BioGRID_ORCS_Cell_line:279, BioSample:SAMN01821563, BioSample:SAMN01821634, BioSample:SAMN01821685, BioSample:SAMN01821731, BioSample:SAMN03471913, BioSample:SAMN10987635, cancercelllines:CVCL_0317, CCRID:1101HUM-PUMC000070, CCRID:3101HUMTCHu170, CCRID:4201HUM-CCTCC00105, CCTCC:GDC0105, Cell_Model_Passport:SIDM00828, ChEMBL-Cells:CHEMBL3308396, ChEMBL-Targets:CHEMBL614580, CLS:300216, Cosmic:716177, Cosmic:716188, Cosmic:724819, Cosmic:907064, Cosmic:912000, Cosmic:1045409, Cosmic:1067221, Cosmic:1933190, Cosmic:2009505, Cosmic:2301553, Cosmic:2307731, Cosmic:2560245, Cosmic:2764533, Cosmic-CLP:907064, DepMap:ACH-000054, DSMZ:ACC-315, DSMZCellDive:ACC-315, ECACC:85111505, EGA:EGAS00001000610, EGA:EGAS00001000978, ENCODE:ENCBS039VHD, ENCODE:ENCBS225AAA, ENCODE:ENCBS512AAA, ENCODE:ENCBS513AAA, ENCODE:ENCBS617SGR, ENCODE:ENCBS688VJF, ENCODE:ENCBS798NML, ENCODE:ENCBS816VMN, ENCODE:ENCBS937RAY, FANTOM5_SSTAR:10758-110E2, GDSC:907064, GEO:GSM185089, GEO:GSM185090, GEO:GSM256074, GEO:GSM256075, GEO:GSM256076, GEO:GSM256077, GEO:GSM256078, GEO:GSM256079, GEO:GSM256080, GEO:GSM256081, GEO:GSM256082, GEO:GSM256083, GEO:GSM256084, GEO:GSM256085, GEO:GSM256086, GEO:GSM256087, GEO:GSM256088, GEO:GSM256089, GEO:GSM256090, GEO:GSM256091, GEO:GSM256092, GEO:GSM256093, GEO:GSM256094, GEO:GSM256095, GEO:GSM256096, GEO:GSM256097, GEO:GSM256098, GEO:GSM256099, GEO:GSM256100, GEO:GSM256101, GEO:GSM256102, GEO:GSM256103, GEO:GSM256104, GEO:GSM256105, GEO:GSM256106, GEO:GSM256107, GEO:GSM256108, GEO:GSM256109, GEO:GSM256110, GEO:GSM256111, GEO:GSM256112, GEO:GSM256113, GEO:GSM256114, GEO:GSM827307, GEO:GSM887136, GEO:GSM888207, GEO:GSM1669908, GEO:GSM1676302, GEO:GSM1701637, GEO:GSM3585511, GEO:GSM3585512, GEO:GSM3585513, GEO:GSM3585514, IARC_TP53:21378, IBRC:C10104, ICLC:HTL98016, IGRhCellID:HT1080, IZSLER:BS TCL 27, JCRB:IFO50354, JCRB:JCRB9113, KCB:KCB 2013029YJ, KCLB:10121, LiGeA:CCLE_463, LINCS_LDP:LCL-1435, Lonza:744, NCBI_Iran:C437, PharmacoDB:HT1080_625_2019, PRIDE:PXD030304, Progenetix:CVCL_0317, PubChem_Cell_line:CVCL_0317, RCB:RCB1956, TKG:TKG 0202, TOKU-E:1963, Wikidata:Q5636047 |
|
|
CVCL_0317 |
2026-09-05 11:08:09 |
2382 |
HTC-C3
Resource Report
Resource Website
1+ mentions
Discontinued
|
RRID:CVCL_1295
|
Homo sapiens (Human)
|
Thyroid gland anaplastic carcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1516062 PMID:2196988 PMID:9177455 PMID:16924234 PMID:20164919 PMID:23833040 PMID:25877200 PMID:27397505 PMID:30737244 PMID:30894373 PMID:35839778
|
Cancer cell line
|
Female |
HTC/C3, HTC C3, HTCC3 |
|
|
BTO:BTO_0006211, CLO:CLO_0037152, CLO:CLO_0050946, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioSample:SAMN01821636, BioSample:SAMN01821686, BioSample:SAMN03470940, cancercelllines:CVCL_1295, Cell_Model_Passport:SIDM00496, CGH-DB:58-1, ChEMBL-Cells:CHEMBL3308747, ChEMBL-Targets:CHEMBL1075472, Cosmic:924151, Cosmic:2009524, Cosmic:2054084, Cosmic:2613249, Cosmic-CLP:924151, DepMap:ACH-001350, DSMZ:ACC-580, DSMZCellDive:ACC-580, EGA:EGAS00001000978, GDSC:924151, GEO:GSM1669916, IARC_TP53:1306, JCRB:FDSC0042, JCRB:JCRB0164, LINCS_LDP:LCL-1689, PharmacoDB:HTCC3_633_2019, PRIDE:PXD030304, PubChem_Cell_line:CVCL_1295, RCB:RCB0452, Wikidata:Q54896604 |
|
|
CVCL_1295 |
2026-09-05 11:08:12 |
1 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
BCRJ Cat# 0377, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
BCRJ |
0377 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-09-05 11:08:40 |
353 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
KCB Cat# KCB 2011100YJ, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
KCB |
KCB 2011100YJ |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-09-05 11:08:40 |
353 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
IZSLER Cat# BS TCL 29, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
IZSLER |
BS TCL 29 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-09-05 11:08:40 |
353 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
ECACC Cat# 86041809, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
ECACC |
86041809 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-09-05 11:08:40 |
353 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
RCB Cat# RCB1895, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
RCB |
RCB1895 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-09-05 11:08:40 |
353 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
ICLC Cat# HTL96021, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
ICLC |
HTL96021 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-09-05 11:08:40 |
353 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
BCRC Cat# 60014, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
BCRC |
60014 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-09-05 11:08:40 |
353 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
JCRB Cat# JCRB9050, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
JCRB |
JCRB9050 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-09-05 11:08:40 |
353 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
TKG Cat# TKG 0207, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
TKG |
TKG 0207 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-09-05 11:08:40 |
353 |
IPC-298
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1307
|
Homo sapiens (Human)
|
Cutaneous melanoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8325707 PMID:9354451 PMID:11668190 PMID:20164919 PMID:22383533 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
IPC 298, IPC298 |
|
|
BTO:BTO_0005774, CLO:CLO_0006961, EFO:EFO_0006447, CLDB:cl2901, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:413, BioSample:SAMN03471908, BioSample:SAMN10988211, cancercelllines:CVCL_1307, Cell_Model_Passport:SIDM01059, ChEMBL-Cells:CHEMBL3308797, ChEMBL-Targets:CHEMBL1075480, Cosmic:907171, Cosmic:928731, Cosmic-CLP:907171, DepMap:ACH-000915, DSMZ:ACC-251, DSMZCellDive:ACC-251, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:907171, GEO:GSM887163, GEO:GSM888235, GEO:GSM1669940, IARC_TP53:21397, LiGeA:CCLE_533, LINCS_LDP:LCL-1250, PharmacoDB:IPC298_666_2019, PRIDE:PXD030304, Progenetix:CVCL_1307, PubChem_Cell_line:CVCL_1307, Wikidata:Q54897951 |
|
|
CVCL_1307 |
2026-09-05 11:08:47 |
5 |
HuO9N2
Resource Report
Resource Website
|
RCB Cat# RCB2532, RRID:CVCL_2958
|
Homo sapiens (Human)
|
Osteosarcoma
|
Characteristics: Established from a xenograft established in athymic nude mice after two passages., Population: Japanese.
|
PMID:2691514 PMID:25877200
|
Cancer cell line
|
Female |
HUO9N2, HuO 9N2, O9N2 |
RCB |
RCB2532 |
CLO:CLO_0009876, CLO:CLO_0050809, BioSample:SAMN03470948, GEO:GSM320821, JCRB:JCRB0428, LINCS_LDP:LCL-1424, RCB:RCB2532, TKG:TKG 0451, Wikidata:Q54896891 |
|
|
CVCL_2958 |
2026-09-05 11:08:19 |
0 |
HuO9N2
Resource Report
Resource Website
|
JCRB Cat# JCRB0428, RRID:CVCL_2958
|
Homo sapiens (Human)
|
Osteosarcoma
|
Characteristics: Established from a xenograft established in athymic nude mice after two passages., Population: Japanese.
|
PMID:2691514 PMID:25877200
|
Cancer cell line
|
Female |
HUO9N2, HuO 9N2, O9N2 |
JCRB |
JCRB0428 |
CLO:CLO_0009876, CLO:CLO_0050809, BioSample:SAMN03470948, GEO:GSM320821, JCRB:JCRB0428, LINCS_LDP:LCL-1424, RCB:RCB2532, TKG:TKG 0451, Wikidata:Q54896891 |
|
|
CVCL_2958 |
2026-09-05 11:08:19 |
0 |
HuO9N2
Resource Report
Resource Website
|
TKG Cat# TKG 0451, RRID:CVCL_2958
|
Homo sapiens (Human)
|
Osteosarcoma
|
Characteristics: Established from a xenograft established in athymic nude mice after two passages., Population: Japanese.
|
PMID:2691514 PMID:25877200
|
Cancer cell line
|
Female |
HUO9N2, HuO 9N2, O9N2 |
TKG |
TKG 0451 |
CLO:CLO_0009876, CLO:CLO_0050809, BioSample:SAMN03470948, GEO:GSM320821, JCRB:JCRB0428, LINCS_LDP:LCL-1424, RCB:RCB2532, TKG:TKG 0451, Wikidata:Q54896891 |
|
|
CVCL_2958 |
2026-09-05 11:08:19 |
0 |
HuP-T4
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1300
|
Homo sapiens (Human)
|
Pancreatic adenocarcinoma
|
Population: Japanese., Part of: NCI RAS program mutant KRAS cell line panel., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8454916 PMID:11668190 PMID:15126341 PMID:15688027 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25167228 PMID:25485619 PMID:25877200 PMID:26216984 PMID:26589293 PMID:27397505 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
HUP-T4, Hu-P-T4, HuPT4, HUPT4 |
|
|
CLO:CLO_0004301, CLO:CLO_0004302, EFO:EFO_0002208, CLDB:cl1772, CLDB:cl1773, CLDB:cl1774, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:895, BioSample:SAMN03472974, BioSample:SAMN03473381, BioSample:SAMN10988380, cancercelllines:CVCL_1300, Cell_Model_Passport:SIDM00531, ChEMBL-Cells:CHEMBL3308815, ChEMBL-Targets:CHEMBL1075478, Cosmic:907286, Cosmic:2434089, Cosmic-CLP:907286, DepMap:ACH-000213, DSMZ:ACC-223, DSMZCellDive:ACC-223, ECACC:93121056, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:907286, GEO:GSM827185, GEO:GSM887152, GEO:GSM888224, GEO:GSM1374568, GEO:GSM1669923, IARC_TP53:21392, ICLC:HTL95006, IGRhCellID:HuPT4, LiGeA:CCLE_379, LINCS_LDP:LCL-1791, PharmacoDB:HuPT4_645_2019, PRIDE:PXD030304, Progenetix:CVCL_1300, PubChem_Cell_line:CVCL_1300, Wikidata:Q54896895 |
|
|
CVCL_1300 |
2026-09-05 11:08:19 |
10 |
HuT 78
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_0337
|
Homo sapiens (Human)
|
Sezary syndrome
|
Anecdotal: For a number of years it was not known that H9 used by Gallo's lab to isolate HIV-1 (HTLV-III) was in fact a clone of Hut 78 from Minna's lab (PubMed=2567177). This created a controversy between the labs of Minna and Gallo (PubMed=2193399)., Population: Caucasian., Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981)., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2144611 PMID:2193399 PMID:2567177 PMID:2985879 PMID:3159941 PMID:3495441 PMID:3874327 PMID:6151082 PMID:6244013 PMID:6954533 PMID:6975346 PMID:7707540 PMID:8127147 PMID:8806089 PMID:8806090 PMID:8806092 PMID:9738977 PMID:10570904 PMID:11416159 PMID:12068308 PMID:20215515 PMID:22460905 PMID:25355872 PMID:25877200 PMID:30285677 PMID:30894373 PMID:31068700
|
Cancer cell line
|
Male |
Hut 78, HUT 78, HuT-78, HUT-78, HuT78, Hut78, HUT78, NCI-H78 |
|
|
BTO:BTO_0001945, CLO:CLO_0004304, CLO:CLO_0051010, EFO:EFO_0002209, MCCL:MCC:0000233, CLDB:cl1778, CLDB:cl1779, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2770, ATCC:CRM-TIB-161, ATCC:TIB-161, BCRC:60522, BCRJ:0370, BEI_Resources:ARP-89, BioSample:SAMN01821566, BioSample:SAMN03471940, BioSample:SAMN03473203, BioSample:SAMN10987600, cancercelllines:CVCL_0337, CCRID:1101HUM-PUMC000190, CCRID:3101HUMTCHu206, CCTCC:GDC0307, Cell_Model_Passport:SIDM00851, CGH-DB:9026-4, ChEMBL-Cells:CHEMBL3307500, ChEMBL-Targets:CHEMBL613978, CLS:300338, Cosmic:724829, Cosmic:1551450, Cosmic:2153070, Cosmic:2402468, Cosmic:2765583, DepMap:ACH-000509, ECACC:88041901, GEO:GSM887154, GEO:GSM888226, GEO:GSM1374569, IARC_TP53:185, IGRhCellID:HuT78, KCLB:90078, LiGeA:CCLE_696, LINCS_LDP:LCL-2005, Lonza:813, NCBI_Iran:C185, PharmacoDB:HuT78_647_2019, Progenetix:CVCL_0337, PubChem_Cell_line:CVCL_0337, RCB:RCB1934, TKG:TKG 0375, TOKU-E:1977, Wikidata:Q54896909 |
|
|
CVCL_0337 |
2026-09-05 11:08:20 |
284 |